Eric Olson

Array ( [id] => 4464722 [patent_doc_number] => 07935731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Methods for concomitant administration of colchicine and macrolide antibiotics' [patent_app_type] => utility [patent_app_number] => 12/786921 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12223 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935731.pdf [firstpage_image] =>[orig_patent_app_number] => 12786921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266566 [patent_doc_number] => 20100298253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Pharmaceutical Compositions Comprising Forms of 5-Azacytidine' [patent_app_type] => utility [patent_app_number] => 12/787214 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6668 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298253.pdf [firstpage_image] =>[orig_patent_app_number] => 12787214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10514920 [patent_doc_number] => 09241951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Of gastrointestinal health, immunity and performance by dietary intervention' [patent_app_type] => utility [patent_app_number] => 13/321412 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 17350 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286427 [patent_doc_number] => 08642756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Nucleoside phosphoramidates' [patent_app_type] => utility [patent_app_number] => 12/783680 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 33428 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12783680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629929 [patent_doc_number] => 20100311684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'NOVEL TRICYCLIC NUCLEOSIDES OR NUCLEOTIDES AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/776691 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30055 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311684.pdf [firstpage_image] =>[orig_patent_app_number] => 12776691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546137 [patent_doc_number] => 20100222292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES' [patent_app_type] => utility [patent_app_number] => 12/775609 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14469 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222292.pdf [firstpage_image] =>[orig_patent_app_number] => 12775609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677157 [patent_doc_number] => 08816067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans' [patent_app_type] => utility [patent_app_number] => 12/775656 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 16188 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876501 [patent_doc_number] => 08901289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Preparation of nucleotide oligomer' [patent_app_type] => utility [patent_app_number] => 12/775843 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11307 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495694 [patent_doc_number] => 20100286076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'ECTOPARASITICIDAL METHODS AND FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/773041 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3680 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286076.pdf [firstpage_image] =>[orig_patent_app_number] => 12773041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211227 [patent_doc_number] => 20120129801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'BLOOD PARASITICIDE' [patent_app_type] => utility [patent_app_number] => 13/318210 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3491 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129801.pdf [firstpage_image] =>[orig_patent_app_number] => 13318210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446524 [patent_doc_number] => 20100279965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/768173 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11133 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279965.pdf [firstpage_image] =>[orig_patent_app_number] => 12768173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514642 [patent_doc_number] => 20100216743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'THERAPY-ENHANCING GLUCAN' [patent_app_type] => utility [patent_app_number] => 12/767237 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9183 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216743.pdf [firstpage_image] =>[orig_patent_app_number] => 12767237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11282651 [patent_doc_number] => 09498489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Antimetabolite agent combinations in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/762768 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 13903 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12762768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851286 [patent_doc_number] => 08877969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition' [patent_app_type] => utility [patent_app_number] => 12/759549 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25661 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12759549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114839 [patent_doc_number] => 08158639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Non-sedating barbiturate compounds as neuroprotective agents' [patent_app_type] => utility [patent_app_number] => 12/759264 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5829 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158639.pdf [firstpage_image] =>[orig_patent_app_number] => 12759264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484711 [patent_doc_number] => 20110250259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Method of treating and preventing breast diseases and breast cancer with medicated formula' [patent_app_type] => utility [patent_app_number] => 12/798723 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3074 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250259.pdf [firstpage_image] =>[orig_patent_app_number] => 12798723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725602 [patent_doc_number] => 08404718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Combinations of pyrazole kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/752772 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 79681 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12752772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644519 [patent_doc_number] => 20100227852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/661639 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33821 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227852.pdf [firstpage_image] =>[orig_patent_app_number] => 12661639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424228 [patent_doc_number] => 20100168053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ORAL DELIVERY SYSTEM FOR METHYLCOBALAMIN TO TREAT DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/723421 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4573 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168053.pdf [firstpage_image] =>[orig_patent_app_number] => 12723421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9233034 [patent_doc_number] => 08598338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Compositions and methods for using a solid support to purify DNA' [patent_app_type] => utility [patent_app_number] => 12/718713 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12227 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12718713 [rel_patent_id] =>[rel_patent_doc_number] =>)